# Gelatines in Pediatric PatientS

> **NCT02495285** · — · COMPLETED · sponsor: **B. Braun Melsungen AG** · enrollment: 601 (actual)

## Conditions studied

- Treatment of Hypovolemia and Shock

## Interventions

- **DRUG:** Gelofusine 4%
- **DRUG:** Gelaspan 4%

## Key facts

- **NCT ID:** NCT02495285
- **Lead sponsor:** B. Braun Melsungen AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2020-05
- **Final completion:** 2020-05
- **Target enrollment:** 601 (ACTUAL)
- **Last updated:** 2024-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02495285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02495285, "Gelatines in Pediatric PatientS". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02495285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*